Related references
Note: Only part of the references are listed.A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors
Ann M. Gregus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain
A. L. Krarup et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
TRPV1-related modulation of spinal neuronal activity and behavior in a rat model of osteoarthritic pain
Katharine L. Chu et al.
BRAIN RESEARCH (2011)
An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects
Patrick Round et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents
Amol M. Patwardhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Deorphanization of TRPV1 and the Emergence of Octadecadienoids as a New Class of Lipid Transmitters
Christopher M. Flores et al.
MOLECULAR INTERVENTIONS (2010)
A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model
Pamela S. Puttfarcken et al.
PAIN (2010)
Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia
Amol M. Patwardhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli
William D. Willis
EXPERIMENTAL BRAIN RESEARCH (2009)
Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Arpad Szallasi et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Contributions of Central and Peripheral TRPV1 Receptors to Mechanically Evoked and Spontaneous Firing of Spinal Neurons in Inflamed Rats
Steve McGaraughty et al.
JOURNAL OF NEUROPHYSIOLOGY (2008)
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain
Maulik D. Jhaveri et al.
NEUROPHARMACOLOGY (2008)
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Arpad Szallasi et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Quantitative profiling of epoxyeicosatrienoic, hydroxyeicosatetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography/electrospray ionization tandem mass spectrometry
Ji-Hong Zhang et al.
ANALYTICAL BIOCHEMISTRY (2007)
Biochemistry and pharmacology of endovanilloids
Katarzyna Starowicz et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Inflammatory pain: The cellular basis of heat hyperalgesia
Jiehong Huang et al.
CURRENT NEUROPHARMACOLOGY (2006)
Bio-markers of lipid peroxidation in vivo: Hydroxyoctadecadienoic acid and hydroxycholesterol
Yasukazu Yoshida et al.
BIOFACTORS (2006)
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
A Tóth et al.
MOLECULAR BRAIN RESEARCH (2005)
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties
NR Gavva et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
N Clayton et al.
PAIN (2002)
Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones
PJ Millns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The vanilloid receptor: A molecular gateway to the pain pathway
MJ Caterina et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology
VA Ziboh et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances
SW Hwang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
MJ Caterina et al.
SCIENCE (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
